Skip to main content
. 2023 Sep 28;14:1256946. doi: 10.3389/fphar.2023.1256946

FIGURE 7.

FIGURE 7

Characteristic of in vitro studies regarding the effect of use of ursolic acid to treat chronic inflammatory and oxidative stress system lesions on inflammatory markers. Interleukin-1beta (IL-1β) (A), Interleukin-6 (IL-6) (B), Interleukin-8 (IL-8) (C) and Tumor necrosis factor-alpha (TNF-α) (D).